Proper response of normal stem cells (NSC) to motomorphogens and chemoattractants plays a pivotal role in organ development and renewal/regeneration of damaged tissues. Similar chemoattractants may also regulate metastasis of cancer stem cells (CSC). Growing experimental evidence indicates that both NSC and CSC express G-protein-coupled seven-transmembrane span receptor CXCR4 and respond to its specific ligand a-chemokine stromal derived factor-1 (SDF-1), which is expressed by stroma cells from different tissues. In addition, a population of very small embryonic-like (VSEL) stem cells that express CXCR4 and respond robustly to an SDF-1 gradient was recently identified in adult tissues. VSELs express several markers of embryonic and primordial germ cells. It is proposed that these cells are deposited early in the development as a dormant pool of embryonic/pluripotent NSC. Expression of both CXCR4 and SDF-1 is upregulated in response to tissue hypoxia and damage signal attracting circulating NSC and CSC. Thus, pharmacological modulation of the SDF-1-CXCR4 axis may lead to the development of new therapeutic strategies to enhance mobilization of CXCR4 þ NSC and their homing to damaged organs as well as inhibition of the metastasis of CXCR4 þ cancer cells.
Introduction
Both organogenesis and tissue/organ regeneration depend on a small population of self-renewing stem cells. In order to play effectively a role in all of these processes, normal stem cells (NSC) have to be able to respond properly to a gradient of motomorphogens that direct their migration. Similar molecular mechanisms may also regulate the migration/metastasis of putative cancer stem cells (CSC). [1] [2] [3] [4] Growing experimental evidence also indicates that malignancy arises from maturation arrest of stem cells -rather than dedifferentiation of somatic cells. [5] [6] [7] Accordingly, stem cells, in contrast to somatic cells, are a long-lived population of cells and thus may become the subject of accumulating mutations that are crucial for the initiation/progression of cancer. More importantly, stem cells may maintain these mutations in the stem cell compartment by passing them to daughter stem cells. It is hypothesized that CSC, not only derive from transformed NSC, but also later on, control cancer development by being responsible for tumor re-growth and metastasis after unsuccessful radio-chemotherapy. [1] [2] [3] [4] Thus, it should not be surprising that NSC and CSC share similar surface markers. NSC and probably most of the CSC express the seven-transmembrane span G-protein-coupled receptor CXCR4 and respond to a chemotactic gradient of its specific ligand, a-chemokine stromalderived factor-1 (SDF-1). 8 In this review, we will discuss the concept that the CXCR4-SDF-1 axis may regulate the trafficking of NSC during development and regeneration processes similarly as it may promote metastasis of CSC.
The role of the SDF-1-CXCR4 axis in normal development and hematopoiesis
Chemokines, small proinflammatory chemoattractant cytokines that bind to specific G-protein-coupled seven-span transmembrane receptors, are the major regulators of cell trafficking and adhesion. [9] [10] [11] [12] More than 50 different chemokines and 20 different chemokine receptors have been cloned. 12 Chemokines usually bind to multiple receptors, and the same receptor may bind to more than one chemokine. However, there is one exception to this rule: SDF-1, which binds exclusively to CXCR4, and has CXCR4 as its only receptor. [8] [9] [10] [11] [12] [13] [14] [15] Recently, a new putative receptor called RDC1 for SDF-1 had been described; 16 however, its potential role in regulating cell trafficking awaits confirmation by other laboratories.
Migration of stem cells, which is a key developmental process, is regulated by several redundant and overlapping pathways involving growth factors, cytokines and chemokines. Thus, usually knockout of one of the factor/receptor axis could be to a large extent compensated by other motomorphogens. However, knockouts of CXCR4 or SDF-1 results in a significant defect of colonization of embryonic bone marrow (BM) by hematopoietic stem cells (HSC), and defect in the development of heart, brain and large vessels. [17] [18] [19] As a result of this, CXCR4 and SDF-1 knockouts are lethal and these embryos die in utero.
In mammals, the first primitive HSC are found in the yolk sac and the first definitive HSC, a few days later in the para-aortic splanchnopleura -called the aorta-gonad-mesonephros (AGM) region. 20 Interestingly, the AGM region is a crossroad through which a population of primordial germ stem cells (PGC) migrate during early embryogenesis on their way to the genital ridges. These cells are also CXCR4 þ and respond robustly to an SDF-1 gradient. 21, 22 It was proposed that pluripotent PGC could differentiate into HSC and could be a potential source of definitive HSC in embryos during gastrulation. 23 This interesting concept, however, requires further studies. From the yolk sack and/or AGM region, HSC migrate to the fetal liver, which during the second trimester of gestation becomes the major mammalian hematopoietic organ. 20 By the end of the second trimester of gestation, HSC leave the fetal liver and colonize BM tissue.
The fact that HSC in CXCR4 À/À or SDF-1 À/À mice migrate properly from the yolk sac and AGM region to the fetal liver suggests that at this time of development another chemoattractant is responsible for migration of these cells. 13, 18 In contrast colonization of BM during the third trimester of gestation depends on proper function of the SDF-1-CXCR4 axis. 13 By the end of the second trimester of gestation, SDF-1 is upregulated in BM and chemoattracts HSC. Later on in adult life, SDF-1 plays a pivotal role in the retention/homing of these cells in the BM microenvironment. 24 Thus, it is not surprising that perturbation of the SDF-1-CXCR4 axis, as seen for example during granulocyte-colony stimulating factor (G-CSF)-induced mobilization, is essential for the egress of hematopoietic stem/ progenitor cells from BM into peripheral blood (PB). 24 On the other hand, proper functioning of the SDF-1-CXCR4 axis seems to be crucial for directing homing/engraftment of HSC into BM after transplantation. 25 The open question, however, remains if SDF-1 signaling in HSC homing could be replaced by other factors. Two lines of evidence suggest that this may be the case. First, the fact mentioned above that HSC colonize fetal liver in CXCR4
À/À or SDF-1 À/À mice suggests that at least in the early stages of fetal development another chemoattractant/s that guides the migration of HSC exists. 13 Second, it is also well known that HSC isolated from the fetal livers of CXCR4 À/À embryos are able, after transplantation, to engraft in adult BM of wild-type (wt) littermates. 26 In this study, however, fetal liver cells from CXCR4 À/À mice and their wild-type littermates were not titrated before transplantation and a competitive repopulation study was not performed to compare the ability of both sources of transplanted cells to engraft adult animals. 26 Furthermore, the wt mice engrafted with CXCR4 À/À fetal liver HSC had more mature myeloid elements in reconstituted BM owing to premature release of early myeloid cells into PB, as well as defect in B-and T-cell development, 27 and the marrow cells from these animals showed a profound engraftment defect in secondary transplants.
It had been recently demonstrated that fresh steady-state murine BM HSC efficiently compensate for the loss of SDF-1-CXCR4 signaling through engagement of a4-integrin (VLA-4)-vascular cellular adhesion molecule (VCAM)-1 axis. 28 Whether this integrin axis may compensate for the lack of CXCR4 signaling during colonization of fetal liver by HSC from CXCR4 À/À or SDF-1 À/À mice and guides engraftment of CXCR4 À/À fetal liver HSC cells after transplantation into normal littermates is not clear at this point. Alternatively, it is possible that engraftment of CXCR4 À/À HSC could be somehow compensated by the RDC1 receptor mentioned above, 16 or perhaps by a recently described homing mechanisms involving a calcium-sensing receptor. 29 No CXCR4/SDF-1 deficiencies have been described so far in humans. Based on murine knockout data, we assume such defects to be lethal. In contrast, however, an activating mutation of CXCR4 in patients suffering from warts, hypogammaglobulinemia, immunodeficiency and myelokathexis (WHIM) syndrome has been reported recently. 30 The molecular basis for all of these mutations is truncations in the C terminus of CXCR4. 30 Lymphoblastoid cells derived from these patients have greater calcium flux than cells from normal donors, consistent with deregulated signaling by the mutant receptor. This latter observation supports the idea that the C-terminal portion of CXCR4 is crucial for receptor desensitization and protects its hyperactivity. 31 It would be interesting to determine whether the WHIM mutation has any impact on trafficking of NSC. 43 and retina pigment-epithelium 44 ( Table 1 ). All of these cells seem, not only to express functional CXCR4 on their surface, but also to follow an SDF-1 gradient. 4 Thus, CXCR4 emerges as a new stem cell marker and SDF-1 seems to be one of the most important chemoattractants for CXCR4 þ NSC.
Cancer cells express CXCR4
Evidence supports that many, if not all, tumors depend on a small population of CSC for their continuous growth ( Figure 1 ). murine and human prostate [50] [51] [52] and murine lung cancers. 53 It is known that NSC and CSC share many characteristics. First, their capacity for self-renewal renders them essentially immortal. Second, both types of cells possess long telomeres, high activity of telomerase and high expression of ABC transporters (efflux pump) that is responsible for their relative resistance to certain types of cytostatics. At the molecular level, several similar pathways are involved in their self-renewal/ proliferation (Wnt, Sonic Hedhehog and Notch signaling, Polycomb genes -Bmi-1, EZH2). What is important for the topic of this review is that NSC and CSC also share similar surface antigens including CXCR4. [5] [6] [7] Almost all of the tumors described so far were found to be CXCR4 þ and respond to an SDF-1 gradient (Table 1) . Therefore, CXCR4 could be potentially employed in addition to other antigens (e.g., Sca-1 in mice or CD133 in humans) as a marker to identify/isolate both NSC from normal tissues, as well as CSC from growing solid tumors or leukemias. 4, 54 The expression of CXCR4 on malignant cells directly implies that the SDF-1-CXCR4 axis may influence the biology of cancer and play a pivotal role in directing the metastasis of CXCR4 þ tumor cells by chemoattracting them to organs that highly express SDF-1 (e.g., lymph nodes, lungs, liver or bones). Supporting this notion, it has been recently reported that several CXCR4 þ cancers (e.g., breast, ovarian, prostate cancers, as well as rhabdomyosarcoma and neuroblastoma) metastasize to the bones and lymph nodes in an SDF-1-dependent manner. [55] [56] [57] [58] [59] As mentioned, CXCR4 is also expressed on cells from several hematopoietic malignancies. For example, the SDF-1-CXCR4 axis is responsible for retention in BM of acute lymphoid leukemia and acute myeloid leukemia (AML) cells. 54 CXCR4, by facilitating VLA-4-VCAM-1 interactions of AML cells, may increase their survival and accounts for anticancer drug resistance. 60 Similarly, CXCR4 signaling increases survival of CLL cells. SDF-1 was reported to be responsible for deregulated adhesion and integrin-dependent BM retention of Philadelphia (Ph) þ CD34 þ cells in chronic myeloid leukemia (CML) patients. 61 On the other hand, p210 bcr was found to inhibit SDF-1 chemotactic responses via alteration of CXCR4 signaling and downregulation of CXCR4 expression in CML cells. 62 Finally, elevated serum levels of SDF-1 are associated with increased osteoclast activity and osteolytic bone disease in multiple myeloma (MM) patients. 63 Regulation of CXCR4 expression CXCR4 expression/function is regulated at several levels ( Figure 2) . First, CXCR4 is regulated at the transcriptional level by hypoxia. Hypoxia-inducible factor-1 alpha (HIF-1a) in cooperation with nuclear factor-kb (NF-kb) was found to upregulate expression of CXCR4. 64, 65 Second, CXCR4 is subject to proteolytic degradation by several proteases that are expressed in the hematopoietic microenvironment and serum (e.g., cathepsin G, elastase, dipeptidylpeptidase). 66, 67 Third, CXCR4 after binding SDF-1 undergoes dimerization, and the activated CXCR4-SDF-1 complex is rapidly internalized from the cell surface in a mechanism involving G-protein-coupled receptor kinases followed by the binding of b-arrestin.
68 CXCR4 after interaction with SDF-1 is internalized from the surface and subsequently is re-circulated from the endosomal compartment at different rates. Fourth, functionality of the CXCR4 receptor depends on its incorporation into membrane lipid domains called lipid rafts and several signals from other membrane receptors (e.g., G-protein-coupled C3a anaphylatoxin receptorC3aR) or integrins may increase the incorporation of CXCR4 into membrane lipid rafts, enhancing its signaling. 69, 70 Finally, CXCR4 is the subject of negative regulation by regulators of G-protein signaling (RGS) proteins. This family of proteins may regulate CXCR4 signaling differently in different tissues. For example, while RGS16 was described to inhibit Third, CXCR4 after interaction with SDF-1 is internalized from the surface and is recirculated from the endosomal compartment at different rates. Fourth, functionality of the CXCR4 receptor depends on its incorporation into membrane lipid rafts, and several signals from other membrane receptors may increase the incorporation of CXCR4 into membrane lipid rafts, increasing its signaling. Finally, CXCR4 is the subject of negative regulation by RGS proteins and lipid phosphatase activity of tumor suppressor PTEN. 39 total body irradiation and after tissue damage related to chemotherapy. 75 This suggests that SDF-1 may play a pivotal role in directing CXCR4
þ NSC necessary for organ/tissue regeneration, 4 implicating this chemokine as an important maintenance factor in postnatal tissue repair.
Studies at the molecular level show that SDF-1 expression is upregulated in endothelial cells by HIF-1a. 76 Supporting this is the finding that the SDF-1 promoter, as the CXCR4 promoter, contains HIF-1a binding sites, and HIF-1a binds to these sequences, as revealed by chromatin immunoprecipitation analysis. 76 Thus, HIF-1a elevates SDF-1 expression in hypoxic/ damaged tissues, which leads to chemoattraction of CXCR4 þ NSC that participate in regeneration. Therefore, SDF-1 appears to be an important indicator of tissue/organ hypoxia/injury and is involved in the active recruitment of NSC for repair of damaged tissue. Since, as stated previously, HIF-1a and NF-kb also upregulate the expression of CXCR4, 65 these factors would appear to regulate the SDF-1-CXCR4 axis at both the ligand and receptor levels. This confers another important argument for a pivotal role of the SDF-1-CXCR4 axis in maintaining postnatal tissue repair. Expression of both SDF-1 and CXCR4 is also controlled by von Hippel-Lindau (VHL) tumor suppressor protein. 77 As a result of VHL loss of function, SDF-1 and CXCR4 are upregulated in hemangioblastomas and clear-cell renal cancers. 78 Conversely, the expression of SDF-1 was found to be downregulated by steroids, 79 G-CSF 80 and transforming growth factor (TGF)-b1. 81 On the other hand, it was reported that low levels of TGF-b1 can modulate SDF-1 responsiveness of CD34 þ cells and thus facilitate SDF-1-mediated retention and nurturing of stem/progenitor cells in BM. 82 As a strong correlation exists between chronic inflammation and tumor progression/metastasis, inflammation-driven expression of SDF-1 may also play an important role in dissemination/ metastasis of CSC. A similar tissue damage-related mechanism may also induce a 'pro-metastatic SDF-1-enriched' environment for CXCR4
þ tumor stem cells in organs damaged by radiochemotherapy. 4, 75 This could lead to an unwanted spread and metastasis of CXCR4 þ CSC that survived anticancer treatment.
Biological effects of the SDF-1-CXCR4 axis
The SDF-1-CXCR4 axis activates several signaling pathways in target cells crucial for both their trafficking and interaction with the intercellular environment. Extensive studies have been also made on the biological effects and signaling pathways of the SDF-1-CXCR4 axis in normal and malignant cells ( Figure 2 ). As reported, SDF-1's major biological effects are related to the ability of this chemokine to induce (i) motility, (ii) chemotactic responses, (iii) adhesion and (iv) secretion of metalloproteinsases and angiopoietic factors (e.g., vascular endothelial growth factor) in cells bearing cognate CXCR4. 4 SDF-1 also increases adhesion of cells to VCAM-1, intercellular adhesion molecule-1, fibronectin and fibrinogen by activating/modulating the function of several cell surface integrins. 83 There is some controversy regarding whether SDF-1, besides regulating the trafficking of cells, also directly affects their proliferation and survival. 9, 84 In some studies, SDF-1 has been reported to increase the proliferation of myeloid progenitor cells. 11 Moreover, it has been suggested that SDF-1 may be secreted by hematopoietic stem/progenitor cells and may be involved in autocrine/ paracrine regulation of their development and survival. 85 The most important pathways involved in signaling from activated CXCR4 include activation of calcium flux, focal adhesion components, such as proline-rich kinase-2 (Pyk-2), Crk-associated substrate (p130Cas), focal adhesion kinase, paxilin, Nck, Crk, Crk-L, protein kinase C, phospholipase C-g (PKC-g), the mitogen-activated protein kinase (MAPK) p42/44-ELK-1 and PI-3K-AKT-NF-kB axes. 4, 65, [85] [86] [87] JAK2, JAK3 86, 87 and Tyk-2 87 may also associate in some cell types with CXCR4 and are probably activated by transphosphorylation in a Ga iindependent manner. 87 Recently, the major role of an atypical isoform of PKC (PKCz) has been proposed to play a crucial role in stem cell trafficking. 88 Strong phosphorylation of focal adhesion components, MAPK p42/44 and serine-threonine kinase AKT is observed within seconds of CXCR4 activation. 86, 89 CXCR4 signaling also involves the Ras-activated signaling pathway, several src-related kinases such as Src, Lyn, Fyn and Lck, T-cell activating molecule ZAP-70 and vav. 90 Recent evidence from other [91] [92] [93] and our 70 laboratories indicates the role of small GTPases in CXCR4 signaling. Activation of these GTPases is crucial for cell migration to an SDF-1 gradient. [91] [92] [93] On the other hand, a recent report indicates that the RasGAP-associated docking protein p62Dok-1 negatively regulates chemotaxis of the Jurkat T-cell line. 94 Strong evidence exists that the protein-tyrosine phosphatases SHIP1 and SHIP2, as well as membrane-expressed hematopoietic phosphatase CD45, are also involved in the modulation of CXCR4 signaling. 95 CXCR4 signaling is also negatively regulated by the RGS proteins 71, 72 and lipid phosphatase activity of tumor suppressor phosphatase and tensin homolog (PTEN) 96 ( Figure 2 ).
Concept of circulation of CXCR4 þ non-hematopoietic NSC
More and more evidence indicates that during tissue/organ injury CXCR4 þ , non-hematopoietic NSC may be mobilized from their tissue location (e.g., BM) into PB in an attempt to regenerate damaged organs. 97, 98 This mechanism had been proposed for heart infarct, 39, 99 107 Accordingly, during these various organ/tissue injury models, there were circulating cells identified in PB that express markers for endothelial-, mesenchymal-, cardiac-, skeletal muscle-, liver-, kidney, neural-and bone-NSC. The presence of non-HSC was also reported in mobilized PB during pharmacological mobilization by G-CSF or in cord blood, which could be considered as neonatal-mobilized PB in response to delivery stress. 73 It is hypothesized that NSC are released from their niches in an attempt to contribute to regeneration of damaged organs. However, the danger exists that these cells, if mobilized at the wrong time and incorporated into the wrong place, may contribute to the development of some pathologies as seen, for example, during the development of diabetic neuropathy with an experimentally induced stomach cancer by Heliobacter pylori infection 110 and in the development of intestinal adenocarcinomas (Dr EW Scott, personal communication). In both situations, development of cancerous lesions was proceeded by an upregulation of SDF-1 expression in gastric 110 or intestinal mucosa, respectively.
Furthermore, circulating stem cells may not only initiate but also contribute to tumor growth. Thus, a tumor being a 'wound that never heals' may contain chemoattracted NSC. The best identified populations of NSC that are chemoattracted by tumors are circulating endothelial stem cells. 111, 112 These cells play an important role in tumor vascularization. It is also well known that tumors contain BM-derived myofibroblasts and fibroblasts. 113 Both endothelial progenitors and robust migrating sub-populations of stroma cells express CXCR4 and respond to an SDF-1 gradient.
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CXCR4
þ VSEL stem cells identified in adult tissues
Almost 150 years ago, Rudolf Virchow and Julius Connheim proposed the concept that adult tissues contain embryonic remnants that were 'lost' during developmental organogenesis and lie dormant and that this population of dormant embryonic stem cells may give rise to malignancies.
1,116
Thus, embryonic stem cells may be, in fact, present in a dormant state in adult tissues. Very recently, we identified in adult BM at the single-cell level a population of stem cells that display a similar morphology and express markers characteristic for early embryonic stem cells. 117 Accordingly, by employing multiparameter sorting we isolated from murine BM a homogenous population of rare (B0.02% of BMMNC) Sca-1 þ lin À CD45 À cells that express by real-time quantitative polymerase chain reaction and immunhistochemistry markers of PSC such as SSEA-1, Oct-4, Nanog and Rex-1. Direct electronmicroscopical analysis revealed that these cells are small (B2-4 mm), possess large nuclei surrounded by a narrow rim of cytoplasm and contain open-type chromatin (euchromatin) that is typical for embryonic stem cells. In in vitro cultures, these cells are able to differentiate into all three germ-layer lineages. Of note, these cells are CXCR4 þ and in vitro respond robustly to an SDF-1 gradient. 117 It is likely that VSELs were co-isolated in the past with other cell populations that were enriched in PSC such as, for example, MAPC, 118 MIAMI cells 119 or USSC. 120 To support this presence of embryonic antigen, Oct-4 þ cells were detected in MAPCderived cells, 118 cells isolated from adult human skin 121 or BM. 122 However, because of their very small size, VSELs were probably overlooked and not identified/purified at a single-cell level. The relationship of MAPC, MIAMI cells and USSC with VSELs, MIAMI requires further studies.
The discovery of VSELs may explain one of the most controversial issues of modern biology, which is plasticity of HSC. 123 We hypothesize that the presence of VSELs in BM, and not 'trans-dedifferentiation' of HSC could explain some of the positive results of tissue/organ regeneration as seen by some of the investigators using BM-derived cells. To support this notion, when highly purified HSC were employed for regeneration experiments, VSELs were probably excluded from the preparations of these cells, and thus the 'phenomenon of transdedifferentiation of HSC' and their contribution to regeneration of the damaged tissues often became controversial. On the other hand, as VSELs reside in BM in a dormant state, perhaps appropriate conditions/factors are needed so that they will efficiently home to the damaged tissues and reveal their regenerative potential. Thus, the absence of these conditions could also, on other hand, explain a negative data with BMderived cells in tissue/organ regeneration. 98 The identification of VSELs could also support Virchow's concept of an embryonic origin of cancer. 116 We hypothesize that this population of CXCR4 þ VSEL stem cells is deposited early during development in BM and perhaps also in other tissues and is a source of PSC for tissue/organ regeneration. 117 Figure 3 shows our hypothesis that during early embryogenesis, a population of CXCR4 þ VSELs may migrate from the early epiblast to fetal liver and subsequently BM. VSELs may also seed to other organs and remain there for a certain period of time in a dormant status. We hypothesize that VSELs could be related to a population of PGC, which respond robustly to an SDF-1 gradient and which during early embryogenesis migrate through the embryo proper (e.g., splanchnopleura and AGM region) to genital ridges. [21] [22] [23] It is possible that in response to an SDF-1 gradient, some of these cells could also seed to other organs, such as fetal liver and subsequently BM. To support this hypothesis, both VSELs as PGC are CXCR4
þ Oct-4 þ SSEA-1 þ and are fetal alkaline phosphatase positive. VSELs, however, in comparison to migrating embryos PGC are smaller in size, which could be explained by a fact that they were isolated from the adult BM -where they reside in a 'hibernated state'. Of note, very recently PGC were identified in adult murine testis 124 and porcine skin. 125 On the other hand, we also envision that mutated VSELs remain dormant in postnatal tissues and may be the origin of some tumors. The potential candidates are not only teratomas or germ cell tumors but also several pediatric sarcomas (e.g., rhabdomyosarcoma, neurblastoma, Ewing's sarcoma) and perhaps some solid tumors in adults (e.g., seminomas, dysgerminomas, germinomas). Thus this mobile pool of cells, along with transformed NSC, could become a source of CSC (Figure 1 ). 
Primordial Germ Cell Hypothesis
SPOTLIGHT
Therapeutic modulation of the SDF-1-CXCR4 axis As the SDF-1-CXCR4 axis has emerged as an important regulator of trafficking of NSC and metastasis of CSC, it became a molecular target for various therapeutic interventions (Figure 4) . Small molecular inhibitors of CXCR4 such as T140 and AMD 3100 or blocking antibodies against CXCR4 or SDF-1 are examples of such blocking agents. 126, 127 Blockage of CXCR4 receptor by AMD3100 is currently successfully employed to mobilize HSC from BM into PB. 127 Small molecular inhibitors of CXCR4 (e.g., T140) had been employed to inhibit growth and metastasis of experimental tumors in animal models. 128, 129 Other promising strategies are based on specific blocking of CXCR4 and SDF-1 expression at the mRNA level by employing small interferring RNA (siRNA) or an oligodeoxynucleotide antisense strategy. 130, 131 To support this RNA-mediated interference had been already successfully employed to downregulate expression of CXCR4 in target cells. 130 Similarly, downregulation of HIF-1a by an siRNA strategy may lead to downregulation of the expression of SDF-1 in various tissues and, as a consequence, inhibit spreading of CXCR4 þ tumor cells. 132 Recently, a small molecular inhibitor of transcriptional co-activation of HIF-1a, called chetomin, has been identified. Systemic administration of chetomin-inhibited hypoxia inducible transcription of HIF-1a regulated genes within tumors and inhibited tumor growth in mice. 133 There is no doubt that new, more efficient, powerful compounds free from side effects will emerge with the ability to mobilize NSC and inhibit metastatic behavior of CSC.
On the other hand, increasing responsiveness of HSC to an SDF-1 gradient could enhance their homing after transplantation into BM. One of the possibilities to accomplish this is blockade of cell surface-expressed dipeptidyl-peptidase IV (CD26) by diprotin.
134 CD26 degrades SDF-1 and thus prevents its interaction with CXCR4. Furthermore, as CXCR4 is a lipid raft regulated receptor which signals most optimal if incorporated into membrane lipid rafts, its signaling could be enhanced/ primed by some small molecules (e.g., complement cleavage fragments or hyaluronic acid) or, in contrast, decreased by lipid raft formation inhibitors (e.g., statins). Accordingly, priming of HSC with complement cleavage fragments enhanced homing of HSC in a murine transplant model. 70 On the other hand, blockade of CXCR4 incorporation into membrane lipid rafts by statins inhibited metastasis of murine prostate cancer cells 135 and SDF-1-mediated thrombopoiesis in mice (manuscript in preparation).
In conclusion, the SDF-1-CXCR4 axis plays an important role in several processes related to development, regeneration and development/progression of malignancies. The explanation for this is that both normal and malignant stem cells express functional CXCR4. Thus, several strategies aimed at inhibiting the SDF-1-CXCR4 axis could find practical application in the clinic. Expression of CXCR4 and responsiveness of cells to and SDF-1 gradient could be modulated at several levels. Accordingly expression and/or function of CXCR4 could be inhibited at the transcriptional level by targeting HIF-1a by chetomin, at the translational level, by siRNA or antisense oligodeoxynucleotides and at, the protein receptor by employing CXCR4 blocking molecules (e.g., T140, AMD3100). On the other hand, responsiveness of cells to an SDF-1 gradient could be enhanced by blocking CD26 by diprotin or by increasing incorporation of CXCR4 into membrane lipid rafts by some inflammation-related molecules (e.g., complement cleavage fragments or hylauronic acid).
On the other hand depletion of cell membrane cholesterol and thus inhibition of lipid raft formation (e.g., statins) would decrease responsiveness of cells to an SDF-1 gradient.
